Speaker illustration

Professor Dick De Zeeuw

Groningen (Netherlands (The))

State of the Art: cardiovascular disease prevention with antihyperglycaemic and cholesterol lowering therapy in type 2 diabetes

Event: ESC Congress 2017

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: Cardiovascular disease prevention with antihyperglycaemic and cholesterol lowering therapy in type 2 diabetes

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb